Key result
Dietary supplements and fiber may lower inflammation and cardiovascular risk in lupus.
Why the study?
Systemic lupus erythematosus features high CVD mortality driven by traditional and non-traditional risk factors, but nutritional approaches with immunomodulatory and antioxidant properties may help reduce this risk.
Do nutritional approaches and micronutrient supplementation modulate traditional and non-traditional cardiovascular disease risk factors in patients with systemic lupus erythematosus?
Do nutritional approaches and micronutrient supplementation modulate traditional and non-traditional cardiovascular disease risk factors in patients with systemic lupus erythematosus?
This literature review synthesizes evidence suggesting that immunomodulatory and antioxidant nutrients may help mitigate traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus, though further clinical trials are required to define specific dietary guidelines.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for nutritional CV risk modulation in SLE; prospective trials needed before clinical adoption.
Systemic lupus erythematosus (SLE) is a chronic pathology characterized by a bimodal mortality pattern attributed to clinical disease activity and cardiovascular disease (CVD). A complex interaction between traditional CVD risk factors such as obesity, dyslipidemia, smoking, insulin resistance, metabolic syndrome, and hypertension, as well as the presence of non-traditional CVD risk factors such as hyperhomocysteinemia, pro-inflammatory cytokines, and C-reactive protein levels, has been suggested as a cause of the high prevalence of CVD in SLE patients. On the other hand, environmental factors, such as nutritional status, could influence the disease's prognosis; several nutrients have immunomodulators, antioxidants, and anti-cardiometabolic risk properties which could reduce SLE severity and organ damage by decreasing the development of traditional and non-traditional CVD risk factors. Therefore, this critical literature review discusses the therapeutic potential of nutritional approaches that could modulate the development of the main comorbidities related to CVD risk in SLE patients.
No takes yet. Share an insight, caveat, or question.
Pesqueda-Cendejas et al. (2023) conducted a review in Systemic lupus erythematosus (SLE) at risk for cardiovascular disease. Nutritional approaches and micronutrient supplementation (polyunsaturated fatty acids, vitamins A, B, C, D, E, selenium, coenzyme Q10, probiotics, dietary fiber, calorie restriction) was evaluated on Modulation of traditional and non-traditional cardiovascular disease risk factors and SLE clinical disease activity. Nutritional approaches including omega-3 fatty acids, vitamins A, B, C, D, E, selenium, and dietary fiber may reduce inflammation, dyslipidemia, and cardiovascular risk in systemic lupus erythematosus.
Synapse has enriched 10 related papers. Consider them for comparative context: